Next Article in Journal
Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021
Next Article in Special Issue
Risk Stratification for ECMO Requirement in COVID-19 ICU Patients Using Quantitative Imaging Features in CT Scans on Admission
Previous Article in Journal
Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
Previous Article in Special Issue
Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test
Article

Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19

1
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, PS 11528 Athens, Greece
2
Clinical Trial Institution, General Hospital Jesenice, PS 4270 Jesenice, Slovenia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Renato Millioni
Diagnostics 2021, 11(6), 995; https://doi.org/10.3390/diagnostics11060995
Received: 6 May 2021 / Revised: 27 May 2021 / Accepted: 28 May 2021 / Published: 30 May 2021
The precise diagnosis of COVID-19 is of outmost importance in order to effectively treat patients and prevent SARS-CoV-2 transmission. Herein, we evaluated the sensitivity and specificity of the COVID-19 Antigen Detection Kit (Colloidal Gold—CG) compared with PCR in nasopharyngeal and nasal samples. A total of 114 positive and 244 negative nasopharyngeal specimens confirmed by PCR were used in this comparative study. When the PCR positive Cycle Threshold (Ct) value was ≤25, CG sensitivity was 100%. When the PCR positive Ct value was ≤33, CG sensitivity was 99%. When the PCR positive Ct value was ≤40, CG sensitivity was 89.47%. Regarding nasal swabs, a total of 109 positive and 250 negative specimens confirmed by PCR were used. When the PCR positive Ct value was ≤25, CG sensitivity was 100%. When the PCR positive Ct value was ≤33, CG sensitivity was 96.12%. When the PCR positive Ct value was ≤37, CG sensitivity was 91.74%. Specificity was above 99% regardless of the Ct value of PCR positivity for both nasopharyngeal and nasal specimens. Overall, the CG showed high sensitivity and specificity when the PCR Ct value was less than 33. Therefore, CG can be used for screening early in the disease course. Confirmatory PCR is essential when a false negative result is suspected. View Full-Text
Keywords: SARS-CoV-2; COVID-19; antigen test; nucleocapsid; clinical validation; nasal swab; nasopharyngeal swab SARS-CoV-2; COVID-19; antigen test; nucleocapsid; clinical validation; nasal swab; nasopharyngeal swab
MDPI and ACS Style

Terpos, E.; Ntanasis-Stathopoulos, I.; Skvarč, M. Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19. Diagnostics 2021, 11, 995. https://doi.org/10.3390/diagnostics11060995

AMA Style

Terpos E, Ntanasis-Stathopoulos I, Skvarč M. Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19. Diagnostics. 2021; 11(6):995. https://doi.org/10.3390/diagnostics11060995

Chicago/Turabian Style

Terpos, Evangelos, Ioannis Ntanasis-Stathopoulos, and Miha Skvarč. 2021. "Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19" Diagnostics 11, no. 6: 995. https://doi.org/10.3390/diagnostics11060995

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop